Published Articles on Vitiligo from January through December 2009

Below you will find a list of published articles on vitiligo, subdivided into Review Articles, Clinical Articles, and Basic Science Articles. Each article is linked to its listing in PubMed. Please note that, due to copyright restrictions, the National Vitiligo Foundation can not provide a direct link to the full text or PDF version of the article.

To go back to viewing the most recent articles, click here.

Review Articles

DECEMBER 2009

Nordlund JJ. Nonmelanoma skin cancer in vitiligo patients. J Am Acad Dermatol. 2009 Dec;61(6):1080-1.

Lotti T, Berti S, Moretti S. Vitiligo therapy. Expert Opin Pharmacother. 2009 Dec;10(17):2779-85.

Jalel A, Soumaya GS, Hamdaoui MH. Dermatology life quality index scores in vitiligo: reliability and validity of the tunisian version. Indian J Dermatol. 2009;54(4):330-3.

Falabella R. Vitiligo and the melanocyte reservoir. Indian J Dermatol. 2009;54(4):313-8.

Lahiri K. Evolution and evaluation of autologous mini punch grafting in vitiligo. Indian J Dermatol. 2009;54(2):159-67.

Khunger N, Kathuria SD, Ramesh V. Tissue grafts in vitiligo surgery - past, present, and future. Indian J Dermatol. 2009;54(2):150-8.

Talsania N, Lamb B, Bewley A. Vitiligo is more than skin deep: a survey of members of the Vitiligo Society. Clin Exp Dermatol. 2009 Dec 8.


NOVEMBER 2009

Kakourou T. Vitiligo in children. World J Pediatr. 2009 Nov;5(4):265-8.

Osman AM, Elkordufani Y, Abdullah MA. The psychological impact of vitiligo in adult Sudanese patients. Afr J Psychiatry (Johannesbg). 2009 Nov;12(4):284-6.


OCTOBER 2009

Gawkrodger DJ. Vitiligo: what general physicians need to know. Clin Med. 2009 Oct;9(5):408-9.

Gawkrodger DJ. Pseudocatalase and narrowband ultraviolet B for vitiligo: clearing the picture. Br J Dermatol. 2009 Oct;161(4):721-2.

Anbar TS, Abdel-Raouf H, Awad SS, Ragaie NH, Abdel-Rahman AT. Presence of eosinophils in the inflammatory infiltrate of nonsegmental vitiligo:retrospective study. Clin Exp Dermatol. 2009 Oct;34(7):e496-7.


SEPTEMBER 2009

Alzolibani A. Genetic epidemiology and heritability of vitiligo in the Qassim region of Saudi Arabia. Acta Dermatovenerol Alp Panonica Adriat. 2009 Sep;18(3):119-25.

Michelsen D. The Double Strike Hypothesis of the vitiligo pathomechanism: New approaches to vitiligo and melanoma. Med Hypotheses. 2009 Sep 10.


JULY 2009

Linthorst Homan MW, Spuls PI, de Korte J, Bos JD, Sprangers MA, Wietze van der Veen JP. The burden of vitiligo: Patient characteristics associated with quality of life. J Am Acad Dermatol. 2009 Jul 2.

Boissy RE, Spritz RA. Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff. Exp Dermatol. 2009 Jul; 18(7): 583-5.

Kostopoulou P, Jouary T, Quintard B, Ezzedine K, Marques S, Boutchnei S, Taieb A. Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral centre. Br J Dermatol. 2009 Jul; 161(1): 128-33.

Radtke MA, Schäfer I, Gajur A, Langenbruch A, Augustin M. Willingness-to-pay and quality of life in patients with vitiligo. Br J Dermatol. 2009 Jul; 161(1): 134-9.


JUNE 2009

Halder RM, Chappell JL. Vitiligo update. Semin Cutan Med Surg. 2009 Jun; 28(2): 86-92.

Isenstein AL, Morrell DS, Burkhart CN. Vitiligo: treatment approach in children. Pediatr Ann. 2009 Jun; 38(6): 339-44.

Alghamdi KM. A survey of vitiligo management among dermatologists in Saudi Arabia. J Eur Acad Dermatol Venereol. 2009 Jun 1.

Kim do Y, Lee JW, Whang SH, Park YK, Hann SK, Shin YJ. Quality of life for Korean patients with vitiligo: Skindex-29 and its correlation with clinical profiles. J Dermatol. 2009 Jun; 36(6): 317-22.


MAY 2009

Singh AK, Karki D. Micropigmentation: Tattooing for the treatment of lip vitiligo. J Plast Reconstr Aesthet Surg. 2009 May 27.

Parsad D, Kanwar AJ. Topical vitamin D(3) analogues in the treatment of vitiligo. Pigment Cell Melanoma Res. 2009 May 5.

Birlea SA, Costin GE, Norris DA. New insights on therapy with vitamin D analogs targeting the intracellular pathways that control repigmentation in human vitiligo. Med Res Rev. 2009 May; 29(3): 514-46.


MARCH 2009

Fernandes NC, Campos MM. Childhood vitiligo and thyroid disease. An Bras Dermatol. 2009 Mar-Apr; 84(2): 200-2.

Namazi MR, Chee Leok GO. Vitiligo and diet: a theoretical molecular approach with practical implications. Indian J Dermatol Venereol Leprol. 2009 Mar-Apr; 75(2): 116-8.

Kyriakis KP, Palamaras I, Tsele E, Michailides C, Terzoudi S. Case detection rates of vitiligo by gender and age. Int J Dermatol. 2009 Mar; 48(3): 328-9.

Nicolaidou E, Antoniou C, Stratigos A, Katsambas AD. Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: a review. J Am Acad Dermatol. 2009 Mar; 60(3): 470-7.


FEB 2009

Cunha D, Pacheco FA, Cardoso J. Vitiligo: a good prognostic factor in melanoma? Dermatol Online J. 2009 Feb 15; 15(2): 15.

Falabella R, Barona MI. Update on skin repigmentation therapies in vitiligo. Pigment Cell Melanoma Res. 2009 Feb; 22(1): 42-65.

Zhang Z, Xu SX, Zhang FY, Yin XY, Yang S, Xiao FL, Du WH, Wang JF, Lv YM, Tang HY, Zhang XJ. The analysis of genetics and associated autoimmune diseases in Chinese vitiligo patients. Arch Dermatol Res. 2009 Feb; 301(2): 167-73.


JAN 2009

Tanioka M, Miyachi Y. Camouflage for vitiligo. Dermatol Ther. 2009 Jan-Feb; 22(1): 90-3.

Fadzil MH, Norashikin S, Suraiya HH, Nugroho H. Independent component analysis for assessing therapeutic response in vitiligo skin disorder. J Med Eng Technol. 2009; 33(2): 101-9.

Vanscheidt W, Hunziker T. Repigmentation by outer-root-sheath-derived melanocytes: proof of concept in vitiligo and leucoderma. Dermatology. 2009; 218(4): 342-3.

Taïeb A, Picardo M. Clinical practice. Vitiligo. N Engl J Med. 2009 Jan 8; 360(2): 160-9.


Return to top of page

Clinical Articles

DECEMBER 2009

Lee DY, Kim PS, Lee JH. Mixed vitiligo treated by suction blister epidermal grafting: Long-term follow up. J Dermatol. 2009 Dec;36(12):672-3.

Jalel A, Soumaya GS, Hamdaoui MH. Vitiligo treatment with vitamins, minerals and polyphenol supplementation. Indian J Dermatol. 2009;54(4):357-60.

Majid I, Masood Q, Hassan I, Khan D, Chisti M. Childhood vitiligo: response to methylprednisolone oral minipulse therapy and topical fluticasone combination. Indian J Dermatol. 2009;54(2):124-7.

da Silva VB, Kawano DF, Carvalho I, da Conceição EC, de Freitas O, da Silva CH. Psoralen and bergapten: in silico metabolism and toxicophoric analysis of drugs used to treat vitiligo. J Pharm Pharm Sci. 2009;12(3):378-87.

Klahan S, Asawanonda P. Topical tacrolimus may enhance repigmentation with targeted narrowband ultraviolet B to treat vitiligo: a randomized, controlled study. Clin Exp Dermatol. 2009 Dec;34(8):e1029-30.

Lee DY, Choi SC, Park JH, Lee JH, Yang JM, Lee ES. Repigmentation after epidermal grafting of vitiligo epidermis into normal skin in segmental vitiligo. Clin Exp Dermatol. 2009 Dec;34(8):e1019.

Jalel A, Hamdaoui MH. Study of total antioxidant status and glutathione peroxidase activity in tunisian vitiligo patients. Indian J Dermatol. 2009;54(1):13-6.

Iftikhar N, Rahman A, Janjua SA. Vitiligo appearing in striae distensae as a koebner phenomenon. J Coll Physicians Surg Pak. 2009 Dec;19(12):796-7.

Goh BK, Chua XM, Chong KL, DE Mil M, VAN Geel NA. Simplified Cellular Grafting for Treatment of Vitiligo and Piebaldism: The "6-Well Plate" Technique. Dermatol Surg. 2009 Dec 21.

Cervelli V, De Angelis B, Balzani A, Colicchia G, Spallone D, Grimaldi M. Treatment of Stable Vitiligo by ReCell System. Acta Dermatovenerol Croat. 2009;17(4):273-8.

Moore AY. Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders. J Dermatolog Treat. 2009;20(6):328-35.


NOVEMBER 2009

Onsun N, Büyükbabani N, Ummetoğlu O, Cebeci F. Do we have to pay more attention to vitiligo patients? Peculiar histopathological features of primary cutaneous melanoma preceded by vitiligo. J Dermatol. 2009 Nov;36(11):612-5.

Lee DY, Park JH, Lee JH, Yang JM, Lee ES. Is segmental vitiligo always associated with leukotrichia? Examination with a digital portable microscope. Int J Dermatol. 2009 Nov;48(11):1262.


OCTOBER 2009

Choi S, Kim DY, Whang SH, Lee JH, Hann SK, Shin YJ. Quality of life and psychological adaptation of Korean adolescents with vitiligo. J Eur Acad Dermatol Venereol. 2009 Oct 6.

Mulekar SV, Al Eisa A, Delvi MB, Al Issa A, Al Saeed AH. Childhood Vitiligo: A Long-term Study of Localized Vitiligo Treated by Noncultured Cellular Grafting. Pediatr Dermatol. 2009 Oct 4.


SEPTEMBER 2009

Lee DY, Choi SC, Lee JH. Comparison of suction blister and carbon dioxide laser for recipient site preparation in epidermal grafting of segmental vitiligo. Clin Exp Dermatol. 2009 Sep 15.

Kossakowska MM, Cieścińska C, Jaszewska J, Placek WJ. Control of negative emotions and its implication for illness perception among psoriasis and vitiligo patients. J Eur Acad Dermatol Venereol. 2009 Sep 10.


AUGUST 2009

Stinco G, Piccirillo F, Forcione M, Valent F, Patrone P. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo. Eur J Dermatol. 2009 Aug 4.

Gowda S, Tillman DK, Fitzpatrick JE, Gaspari AA, Goldenberg G. Imiquimod-induced vitiligo after treatment of nodular basal cell carcinoma. J Cutan Pathol. 2009 Aug; 36(8): 878-81.

Radakovic S, Breier-Maly J, Konschitzky R, Kittler H, Sator P, Hoenigsmann H, Tanew A. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial. J Eur Acad Dermatol Venereol. 2009 Aug; 23(8): 951-3.


JULY 2009

Lee DY, Choi SC, Lee JH. Generalized vitiligo treated by combination therapy of epidermal graft and systemic corticosteroid. Clin Exp Dermatol. 2009 Jul 29.

Saraceno R, Nisticò SP, Capriotti E, Chimenti S. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study. Dermatol Ther. 2009 Jul-Aug; 22(4) :391-4.

Elgoweini M, Nour El Din N. Response of vitiligo to narrowband ultraviolet B and oral antioxidants. J Clin Pharmacol. 2009 Jul; 49(7): 852-5.

Yuksel EP, Aydin F, Senturk N, Canturk T, Turanli AY. Comparison of the efficacy of narrow band ultraviolet B and narrow band ultraviolet B plus topical catalase-superoxide dismutase treatment in vitiligo patients. Eur J Dermatol. 2009 Jul-Aug; 19(4): 341-4.

Fongers A, Wolkerstorfer A, Nieuweboer-Krobotova L, Krawczyk P, Tóth GG, van der Veen JP. Long-term results of 2-mm punch grafting in patients with vitiligo vulgaris and segmental vitiligo: effect of disease activity. Br J Dermatol. 2009 Jun 22.

Hui-Lan Y, Xiao-Yan H, Jian-Yong F, Zong-Rong L. Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo. Pediatr Dermatol. 2009 May-Jun; 26(3): 354-6.

Farajzadeh S, Daraei Z, Esfandiarpour I, Hosseini SH. The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study. Pediatr Dermatol. 2009 May-Jun; 26(3): 286-91.


JUNE 2009

Borlu M, Cölgeçen E, Evereklioglu C. Behçet's disease and vitiligo in two brothers: coincidence or association? Clin Exp Dermatol. 2009 Jun 22.

Lubaki LJ, Ghanem G, Vereecken P, Fouty E, Benammar L, Vadoud-Seyedi J, Dell'anna ML, Briganti S, Picardo M, Heenen M. Time-kinetic study of repigmentation in vitiligo patients by tacrolimus or pimecrolimus. Arch Dermatol Res. 2009 Jun 23.

El Hoseny SM. Treatment of Upper- and Lower-Extremity Vitiligo with Epidermal Grafts After CO(2) Laser Resurfacing with Systemic and Topical Steroids. Aesthetic Plast Surg. 2009 Jun 16.

Bakis-Petsoglou S, Le Guay JL, Wittal R. A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo. Br J Dermatol. 2009 Jun 11.

Akar A, Tunca M, Koc E, Kurumlu Z. Broadband targeted UVB phototherapy for localized vitiligo: a retrospective study. Photodermatol Photoimmunol Photomed. 2009 Jun; 25(3): 161-3.

Anbar TS, El-Sawy AE, Attia SK, Moftah NH, El-Tonsy MH. Patterns of repigmentation in two cases of hypopigmented type of vitiligo. Photodermatol Photoimmunol Photomed. 2009 Jun; 25(3): 156-8.


MAY 2009

Berti S, Buggiani G, Lotti T. Use of tacrolimus ointment in vitiligo alone or in combination therapy. Skin Therapy Lett. 2009 May; 14(4) :5-7.

Welsh O, Herz-Ruelas ME, Gómez M, Ocampo-Candiani J. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area. Int J Dermatol. 2009 May; 48(5): 529-34.

Back C, Dearman B, Li A, Neild T, Greenwood JE. Noncultured keratinocyte/melanocyte cosuspension: effect on reepithelialization and repigmentation--a randomized, placebo-controlled study. J Burn Care Res. 2009 May-Jun; 30(3): 408-16.


APRIL 2009

Ko WC, Chen YF. Suction blister epidermal grafts combined with CO2 laser superficial ablation as a good method for treating small-sized vitiligo. Dermatol Surg. 2009 Apr; 35(4): 601-6.

Lv Y, Zhang Y, Luan Q. Supplementation with insulin and antioxidants could be advantageous in the treatment of vitiligo. Med Hypotheses. 2009 Apr; 72(4): 480-1.

Kapoor R, Phiske MM, Jerajani HR. Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo. Br J Dermatol. 2009 Apr; 160(4): 861-3.


MARCH 2009

Al-Otaibi SR, Zadeh VB, Al-Abdulrazzaq AH, Tarrab SM, Al-Owaidi HA, Mahrous R, Kadyan RS, Najem NM. Using a 308-nm excimer laser to treat vitiligo in Asians. Acta Dermatovenerol Alp Panonica Adriat. 2009 Mar; 18(1): 13-9.

Eryilmaz A, Seçkin D, Baba M. Pimecrolimus: a new choice in the treatment of vitiligo? J Eur Acad Dermatol Venereol. 2009 Mar 4.

Kishan Kumar YH, Rao GR, Gopal KV, Shanti G, Rao KV. Evaluation of narrow-band UVB phototherapy in 150 patients with vitiligo. Indian J Dermatol Venereol Leprol. 2009 Mar-Apr; 75(2): 162-6.

Hexsel CL, Mahmoud BH, Mitchell D, Rivard J, Owen M, Strickland FM, Lim HW, Hamzavi I. A clinical trial and molecular study of photoadaptation in vitiligo. Br J Dermatol. 2009 Mar; 160(3): 534-9.


FEB 2009

Lee DY, Park JH, Choi SC, Lee JH. Comparison of recipient site preparations in epidermal grafting for vitiligo: suction blister and CO laser. J Eur Acad Dermatol Venereol. 2009 Feb 26.

Sehgal VN. Role of tacrolimus (FK506) 0.1% ointment WW in vitiligo in children and imperatives of combine therapy with Trioxsalen and Silymarin suspension in progressive vitiligo. J Eur Acad Dermatol Venereol. 2009 Feb 31.

Rodríguez-Martín M, García Bustínduy M, Sáez Rodríguez M, Noda Cabrera A. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo. Br J Dermatol. 2009 Feb; 160(2): 409-14.


JAN 2009

Lee DY, Park JH, Park HY, Lee JH. The use of suction blisters for the recipient area in epidermal grafting for vitiligo. J Eur Acad Dermatol Venereol. 2009 Jan 13.

Lee KJ, Lee JH, Lee DY. Successful treatment of vitiligo in a 6-year-old child by topical anaesthesia and epidermal grafting. J Eur Acad Dermatol Venereol. 2009 Jan 8.

Xu AE, Zhang DM, Wei XD, Huang B, Lu LJ. Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo. Int J Dermatol. 2009 Jan; 48(1): 86-90.

Mulekar SV, Al Issa A, Al Eisa A. Treatment of vitiligo on difficult-to-treat sites using autologous noncultured cellular grafting. Dermatol Surg. 2009 Jan; 35(1): 66-71.

Esfandiarpour I, Ekhlasi A, Farajzadeh S, Shamsadini S. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial. J Dermatolog Treat. 2009; 20(1): 14-8.


Return to top of page

Basic Science Articles

DECEMBER 2009

Birlea SA, Gowan K, Fain PR, Spritz RA. Genome-Wide Association Study of Generalized Vitiligo in an Isolated European Founder Population Identifies SMOC2, in Close Proximity to IDDM8. J Invest Dermatol. 2009 Nov 5.


NOVEMBER 2009

Misri R, Khopkar U, Shankarkumar U, Ghosh K. Comparative case control study of clinical features and human leukocyte antigen susceptibility between familial and nonfamilial vitiligo. Indian J Dermatol Venereol Leprol. 2009 Nov-Dec;75(6):583-7.

Jeong KH, Shin MK, Uhm YK, Kim HJ, Chung JH, Lee MH. Association of TXNDC5 Gene Polymorphisms and Non-segmental Vitiligo Susceptibility in the Korean Population. Br J Dermatol. 2009 Nov 10.

Birlea SA, Gowan K, Fain PR, Spritz RA. Genome-Wide Association Study of Generalized Vitiligo in an Isolated European Founder Population Identifies SMOC2, in Close Proximity to IDDM8. J Invest Dermatol. 2009 Nov 5.


OCTOBER 2009

Serarslan G, Yonden Z, Sogut S, Savas N, Celik E, Arpaci A. Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease. Clin Exp Dermatol. 2009 Oct 23.

Zamani M, Tabatabaiefar MA, Mosayyebi S, Mashaghi A, Mansouri P. Possible association of the CD4 gene polymorphism with vitiligo in an Iranian population. Clin Exp Dermatol. 2009 Oct 19.

Soylu S, Gül U, Gönül M, Kılıç A, Cakmak SK, Demiriz M. An Uncommon Presentation of the Co-Existence of Morphea and Vitiligo in a Patient with Chronic Hepatitis B Virus Infection: Is There a Possible Association with Autoimmunity? Am J Clin Dermatol. 2009 Oct 1;10(5):336-338.


SEPTEMBER 2009

Aksoy SN, Erbagci Z, Saygili EI, Sever T, Erbagci AB, Pehlivan S. Analysis of myeloperoxidase promotor polymorphism and enzyme activity in Turkish patients with vitiligo. Eur J Dermatol. 2009 Sep 17.

Jin Y, Riccardi SL, Gowan K, Fain PR, Spritz RA. Fine-Mapping of Vitiligo Susceptibility Loci on Chromosomes 7 and 9 and Interactions with NLRP1 (NALP1). J Invest Dermatol. 2009.


AUGUST 2009

Hariharan V, Klarquist J, Reust MJ, Koshoffer A, McKee MD, Boissy RE, Le Poole IC. Monobenzyl Ether of Hydroquinone and 4-Tertiary Butyl Phenol Activate Markedly Different Physiological Responses in Melanocytes: Relevance to Skin Depigmentation. J Invest Dermatol. 2009 Aug 6.

Anbar TS, Abdel-Raouf H, Awad SS, Ragaie MH, Abdel-Rahman AT. The hair follicle melanocytes in vitiligo in relation to disease duration. J Eur Acad Dermatol Venereol. 2009 Aug; 23(8): 934-9.


JULY 2009

Kumar R, Parsad D, Kaul D, Kanwar A. Liver X receptor expression in human melanocytes, does it have a role in the pathogenesis of vitiligo? Exp Dermatol. 2009 Jul 23.

Salem MM, Shalbaf M, Gibbons NC, Chavan B, Thornton JM, Schallreuter KU. Enhanced DNA binding capacity on up-regulated epidermal wild-type p53 in vitiligo by H2O2-mediated oxidation: a possible repair mechanism for DNA damage. FASEB J. 2009 Jul 29. [Epub ahead of print]

Manini P, Napolitano A, Westerhof W, Riley PA, d'Ischia M. A Reactive ortho-Quinone Generated by Tyrosinase-Catalyzed Oxidation of the Skin Depigmenting Agent Monobenzone: Self-Coupling and Thiol-Conjugation Reactions and Possible Implications for Melanocyte Toxicity. Chem Res Toxicol. 2009 Jul 17.

Waterman EA, Gawkrodger DJ, Watson PF, Weetman AP, Kemp EH. Autoantigens in Vitiligo Identified by the Serological Selection of a Phage-Displayed Melanocyte cDNA Expression Library. J Invest Dermatol. 2009 Jul 9.

Liu L, Li C, Gao J, Li K, Gao L, Gao T. Genetic Polymorphisms of Glutathione S-Transferase and Risk of Vitiligo in the Chinese Population. J Invest Dermatol. 2009 Jul 2.

Jain D, Misra R, Kumar A, Jaiswal G. Levels of malondialdehyde and antioxidants in the blood of patients with vitiligo of age group 11-20 years. Indian J Physiol Pharmacol. 2008 Jul-Sep; 52(3): 297-301.

Moretti S, Fabbri P, Baroni G, Berti S, Bani D, Berti E, Nassini R, Lotti T, Massi D. Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis. Histol Histopathol. 2009 Jul; 24(7): 849-57.

Balci DD, Yonden Z, Yenin JZ, Okumus N. Serum homocysteine, folic acid and vitamin B12 levels in vitiligo. Eur J Dermatol. 2009 Jul-Aug; 19(4): 382-3.

Dwivedi M, Gupta K, Gulla KC, Laddha NC, Hajela K, Begum R. Lack of genetic association of promoter and structural variants of mannan-binding lectin (MBL2) gene with susceptibility to generalized vitiligo. Br J Dermatol. 2009 Jul; 161(1): 63-9.

Diao JS, Zhang X, Xia WS, Zheng Y, Ren J, Wang YM, Gong Z, Xia W, Guo SZ. Aberrant Notch signaling: a potential pathomechanism of vitiligo. Med Hypotheses. 2009 Jul; 73(1): 70-2.


JUNE 2009

Pichler R, Sfetsos K, Badics B, Gutenbrunner S, Berg J, Auböck J. Lymphocyte imbalance in vitiligo patients indicated by elevated CD4+/CD8+ T-cell ratio. Wien Med Wochenschr. 2009; 159(13-14): 337-41.

Cheong KA, Chae SC, Kim YS, Kwon HB, Chung HT, Lee AY. Association of thymic stromal lymphopoietin gene -847C>T polymorphism in generalized vitiligo. Exp Dermatol. 2009 Jun 23.

Cazzaniga S, Sassi F, Mercuri SR, Naldi L. Prediction of Clinical Response to Excimer Laser Treatment in Vitiligo by Using Neural Network Models. Dermatology. 2009 Jun 18.

Ren Y, Yang S, Xu S, Gao M, Huang W, Gao T, Fang Q, Quan C, Zhang C, Sun L, Liang Y, Han J, Wang Z, Zhang F, Zhou Y, Liu J, Zhang X. Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo. PLoS Genet. 2009 Jun; 5(6): e1000523.

Khan R, Satyam A, Gupta S, Sharma VK, Sharma A. Circulatory levels of antioxidants and lipid peroxidation in Indian patients with generalized and localized vitiligo. Arch Dermatol Res. 2009 Jun 2.

Lan CC, Ko YC, Tu HP, Wu CS, Lee CH, Wu CS, Yu HS. Association study between keratinocyte-derived growth factor gene polymorphisms and susceptibility to vitiligo vulgaris in a Taiwanese population: potential involvement of stem cell factor. Br J Dermatol. 2009 Jun; 160(6): 1180-7.

Moretti S, Nassini R, Prignano F, Pacini A, Materazzi S, Naldini A, Simoni A, Baroni G, Pellerito S, Filippi I, Lotti T, Geppetti P, Massi D. Protease-activated receptor-2 downregulation is associated to vitiligo lesions. Pigment Cell Melanoma Res. 2009 Jun; 22(3): 335-8.

Prignano F, Pescitelli L, Becatti M, Di Gennaro P, Fiorillo C, Taddei N, Lotti T. Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin. J Dermatol Sci. 2009 Jun; 54(3): 157-67.


MAY 2009

Zhou Z, Li CY, Li K, Wang T, Zhang B, Gao TW. Decreased methionine sulphoxide reductase A expression renders melanocytes more sensitive to oxidative stress: a possible cause for melanocyte loss in vitiligo. Br J Dermatol. 2009 May 5.

Sravani PV, Babu NK, Gopal KV, Rao GR, Rao AR, Moorthy B, Rao T. Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin. Indian J Dermatol Venereol Leprol. 2009 May-Jun; 75(3): 268-71.

Taher ZA, Lauzon G, Maguiness S, Dytoc MT. Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus. Br J Dermatol. 2009 May 12.

Dammak I, Boudaya S, Ben Abdallah F, Turki H, Attia H, Hentati B. Antioxidant enzymes and lipid peroxidation at the tissue level in patients with stable and active vitiligo. Int J Dermatol. 2009 May; 48(5): 476-80.

Li Y, Chen F, Lin F, Guan C, Wei X, Wan Y, Xu A. VIT1/FBXO11 knockdown induces morphological alterations and apoptosis in B10BR mouse melanocytes. Int J Mol Med. 2009 May; 23(5): 673-8.

Gavalas NG, Gottumukkala RV, Gawkrodger DJ, Watson PF, Weetman AP, Helen Kemp E. Mapping of melanin-concentrating hormone receptor 1 B cell epitopes predicts two major binding sites for vitiligo patient autoantibodies. Exp Dermatol. 2009 May; 18(5): 454-63.

Lv Y, Li Q, Wang L, Gao T. Use of anti-tumor necrosis factor agents: a possible therapy for vitiligo. Med Hypotheses. 2009 May; 72(5): 546-7.


APRIL 2009

Lan CC, Wu CS, Chiou MH, Chiang TY, Yu HS. Low-energy helium-neon laser induces melanocyte proliferation via interaction with type IV collagen: visible light as a therapeutic option for vitiligo. Br J Dermatol. 2009 Apr 30.

Bam M, Bagchi T. Absence of tyrosinase-related protein-2/dopachrome tautomerase transcripts in PBMCs from vitiligo patients. Scand J Immunol. 2009 Apr; 69(4): 366-73.

Birlea SA, Laberge GS, Procopciuc LM, Fain PR, Spritz RA. CTLA4 and generalized vitiligo: two genetic association studies and a meta-analysis of published data. Pigment Cell Melanoma Res. 2009 Apr; 22(2): 230-4.


MARCH 2009

Pan JY, Theng C, Lee J, Goh BK. Vitiligo as an adverse reaction to topical diphencyprone. Ann Acad Med Singapore. 2009 Mar; 38(3): 276-7.

Gönül M, Gül U, Kılınç C, Külcü Çakmak S. Prolactine levels in the patients with vitiligo. J Eur Acad Dermatol Venereol. 2009 Mar 4.

Pehlivan S, Ozkinay F, Alper S, Onay H, Yuksel E, Pehlivan M, Ozkinay C. Association between IL4 (-590), ACE (I)/(D), CCR5 (Delta32), CTLA4 (+49) and IL1-RN (VNTR in intron 2) gene polymorphisms and vitiligo. Eur J Dermatol. 2009 Mar-Apr; 19(2): 126-8.

Li M, Gao Y, Li C, Liu L, Li K, Gao L, Wang G, Zhang Z, Gao T. Association of COX2 functional polymorphisms and the risk of vitiligo in Chinese populations. J Dermatol Sci. 2009 Mar; 53(3): 176-81.

Davids LM, du Toit E, Kidson SH, Todd G. A rare repigmentation pattern in a vitiligo patient: a clue to an epidermal stem-cell reservoir of melanocytes? Clin Exp Dermatol. 2009 Mar; 34(2): 246-8.


FEB 2009

van den Boorn JG, Konijnenberg D, Dellemijn TA, van der Veen JP, Bos JD, Melief CJ, Vyth-Dreese FA, Luiten RM. Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients. J Invest Dermatol. 2009 Feb 26.

Chavan B, Beazley W, Wood JM, Rokos H, Ichinose H, Schallreuter KU. H(2)O(2) increases de novo synthesis of (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin via GTP cyclohydrolase I and its feedback regulatory protein in vitiligo. J Inherit Metab Dis. 2009 Feb; 32(1): 86-94.

Basak PY, Adiloglu AK, Ceyhan AM, Tas T, Akkaya VB. The role of helper and regulatory T cells in the pathogenesis of vitiligo. J Am Acad Dermatol. 2009 Feb; 60(2): 256-60.


JAN 2009

Angrisani RM, Azevedo MF, Pereira LD, Lopes C, Garcia MV. A study on otoacoustic emissions and supression effects in patients with vitiligo. Braz J Otorhinolaryngol. 2009 Jan-Feb; 75(1): 111-5.

Hong CK, Lee MH, Jeong KH, Cha CI, Yeo SG. Clinical analysis of hearing levels in vitiligo patients. Eur J Dermatol. 2009 Jan-Feb; 19(1): 50-6.


Return to top of page